bpv Braun Partners Advises Unilabs on Regulatory Aspects of Acquisition from Mid Europa Partners

bpv Braun Partners Advises Unilabs on Regulatory Aspects of Acquisition from Mid Europa Partners

Deals and Cases
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

BPV Braun Partners has advised Unilabs on regulatory issues related to its acquisition of Alpha Medical Group's laboratories in the Czech Republic and Slovakia from Mid Europa Partners, including environmental and compliance matters.

As reported earlier this week, CMS, working alongside Sidley Austin, advised Mid Europa Partners on the sale, while Baker & McKenzie advised Unilabs on the the transaction. 

The bpv Braun Partners team was led by Managing Partner Arthur Braun and Slovak Partner Igor Augustinic, supported by Senior Associates Ondrej Ponistiak and Monika Kardosova.

Arthur Braun stated that: “We are glad to help Unilabs with its international growth and successful market entry to Czech and Slovak clinical laboratory market. With a value of several hundred million euros, this is one of the largest transactions, both of private equity investors as well as in healthcare in the region since the financial crisis.”